MedPath

Near to Infrared (NIR) Light Neuroprotection in Glaucomatous Optic Neuropathy

Early Phase 1
Conditions
Open Angle Glaucoma
Interventions
Device: Near to infrared light retinal stimulation
Device: Green light stimulation
Registration Number
NCT00844389
Lead Sponsor
Universidad de Valparaiso
Brief Summary

The purpose of the study is to evaluate if near-to-infrared light stimulation can improve retinal ganglion cell function in glaucomatous patients.

Detailed Description

Ganglion cell dysfunction in glaucomatous optic neuropathy has been ascribed to ganglion cell electrophysiological inactivation and to apoptotic cell death. Near-to-infrared light stimulation has been used to induce mitochondrial activation and to prevent apoptotic death through mitochondrial cytochrome oxidase c stimulation. Near-to-infrared light stimulation might be useful to induce ganglion cell activation and inhibit apoptotic cell death.

We propose that near-to-infrared light stimulation can be used as an adjuvant treatment combined with ocular hypotensive treatment in glaucomatous patients.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
40
Inclusion Criteria
  • Clinical diagnose of Ocular Hypertension (cup to disk ratio 0,6 or less, normal Humphrey 24-2 visual field with aplanatic IOP over 21 mmHg) or Mild Glaucoma (cup to disk ratio 0,6 to 0,8, characteristic Humphrey 24-2 visual field defect PSD between 3 and 6 dB).
  • Visual acuity 20/40 or better
Exclusion Criteria
  • Diabetic retinopathy, Multiple Sclerosis, Parkinson disease
  • Refractive error of 3 diopters or more

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
NIR lightNear to infrared light retinal stimulationGroup of patients stimulated with near to infrared light daily stimulation
Green lightGreen light stimulationGroup of patients stimulated with green light.
Primary Outcome Measures
NameTimeMethod
Pattern electroretinogram responseEvery two weeks for 4 months
Secondary Outcome Measures
NameTimeMethod
OCT ganglion cell layer average thickness, Visual Field defectsEvery month for four months

Trial Locations

Locations (1)

Servicio de Oftalmología Hospital Van Buren

🇨🇱

Valparaiso, Chile

© Copyright 2025. All Rights Reserved by MedPath